Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology

被引：31

作者：

Cantinotti, Massimiliano ^{[1
]}

Clerico, Aldo ^{[1
,2
]}

Murzi, Michele ^{[1
]}

Vittorini, Simona ^{[1
]}

Emdin, Michele ^{[1
]}

机构：

[1] Fdn G Monasterio, I-56124 Pisa, Italy

[2] Scuola Super Sant Anna, Pisa, Italy

来源：

CLINICA CHIMICA ACTA | 2008年 / 390卷 / 1-2期

关键词：

BNP; NT-proBNP; cardiac natriuretic hormones; evidence-based laboratory medicine; diagnostic accuracy; pediatric cardiology;

D O I：

10.1016/j.cca.2007.12.020

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 [基础医学];

摘要：

Background: The aim of this review is to understand the clinical usefulness of Brain Natriuretic Peptide (BNP) and N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) in pediatric cardiology. Methods: A computerized literature search on National Library of Medicine using the keywords "BNP assay" and "NT proBNP assay" was performed. Then, we refined the analysis to include only the studies specifically designed to evaluate the clinical usefulness of BNP and NT-proBNP assays in patients with congenital heart disease. Results: BNP and NT-proBNP are useful marker for diagnosis of heart failure, for the assessment of clinical severity and for the follow-up of congenital and pediatric heart diseases. However, results from different studies are often partial and not always univocal. Moreover, reference intervals in pediatric population have not yet been extensively evaluated. Conclusions: BNP and NT-proBNP may be considered helpful markers for the integrated diagnosis and management of pediatric patients, though further studies are needed to support their routine use. (C) 2008 Elsevier B.V. All rights reserved.

引用

页码：12 / 22

页数：11

共 126 条

[1]

ATRIAL NATRIURETIC FACTOR INHIBITS PROLIFERATION OF VASCULAR SMOOTH-MUSCLE CELLS STIMULATED BY PLATELET-DERIVED GROWTH-FACTOR [J].